Ann P Quick1, Qiongling Wang1, Leonne E Philippen1, Giselle Barreto-Torres1, David Y Chiang1, David Beavers1, Guoliang Wang1, Maha Khalid1, Julia O Reynolds1, Hannah M Campbell1, Jordan Showell1, Mark D McCauley1, Arjen Scholten1, Xander H T Wehrens2. 1. From the Department of Molecular Physiology and Biophysics (A.P.Q., Q.W., L.E.P., G.B.-T., J.O.R., H.M.C., J.S., X.H.T.W), Cardiovascular Research Institute (A.P.Q., Q.W., L.E.P., G.B.-T., D.Y.C., D.B., G.W., J.O.R., H.M.C., J.S., M.D.M., X.H.T.W), Medical Scientist Training Program (D.Y.C., D.B., H.M.C.), Department of Medicine (Cardiology) (M.D.M., X.H.T.W), and Pediatrics (X.H.T.W.), Baylor College of Medicine, Houston, TX; Accelerated BS/MD Program, Department of Biology and Biochemistry, University of Houston, TX (M.K.); and Department of Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands (A.S.). 2. From the Department of Molecular Physiology and Biophysics (A.P.Q., Q.W., L.E.P., G.B.-T., J.O.R., H.M.C., J.S., X.H.T.W), Cardiovascular Research Institute (A.P.Q., Q.W., L.E.P., G.B.-T., D.Y.C., D.B., G.W., J.O.R., H.M.C., J.S., M.D.M., X.H.T.W), Medical Scientist Training Program (D.Y.C., D.B., H.M.C.), Department of Medicine (Cardiology) (M.D.M., X.H.T.W), and Pediatrics (X.H.T.W.), Baylor College of Medicine, Houston, TX; Accelerated BS/MD Program, Department of Biology and Biochemistry, University of Houston, TX (M.K.); and Department of Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands (A.S.). wehrens@bcm.edu.
Abstract
RATIONALE: Junctional membrane complexes (JMCs) in myocytes are critical microdomains, in which excitation-contraction coupling occurs. Structural and functional disruption of JMCs underlies contractile dysfunction in failing hearts. However, the role of newly identified JMC protein SPEG (striated muscle preferentially expressed protein kinase) remains unclear. OBJECTIVE: To determine the role of SPEG in healthy and failing adult hearts. METHODS AND RESULTS: Proteomic analysis of immunoprecipitated JMC proteins ryanodine receptor type 2 and junctophilin-2 (JPH2) followed by mass spectrometry identified the serine-threonine kinase SPEG as the only novel binding partner for both proteins. Real-time polymerase chain reaction revealed the downregulation of SPEG mRNA levels in failing human hearts. A novel cardiac myocyte-specific Speg conditional knockout (MCM-Spegfl/fl) model revealed that adult-onset SPEG deficiency results in heart failure (HF). Calcium (Ca2+) and transverse-tubule imaging of ventricular myocytes from MCM-Spegfl/fl mice post HF revealed both increased sarcoplasmic reticulum Ca2+ spark frequency and disrupted JMC integrity. Additional studies revealed that transverse-tubule disruption precedes the development of HF development in MCM-Spegfl/fl mice. Although total JPH2 levels were unaltered, JPH2 phosphorylation levels were found to be reduced in MCM-Spegfl/fl mice, suggesting that loss of SPEG phosphorylation of JPH2 led to transverse-tubule disruption, a precursor of HF development in SPEG-deficient mice. CONCLUSIONS: The novel JMC protein SPEG is downregulated in human failing hearts. Acute loss of SPEG in mouse hearts causes JPH2 dephosphorylation and transverse-tubule loss associated with downstream Ca2+ mishandling leading to HF. Our study suggests that SPEG could be a novel target for the treatment of HF.
RATIONALE: Junctional membrane complexes (JMCs) in myocytes are critical microdomains, in which excitation-contraction coupling occurs. Structural and functional disruption of JMCs underlies contractile dysfunction in failing hearts. However, the role of newly identified JMC protein SPEG (striated muscle preferentially expressed protein kinase) remains unclear. OBJECTIVE: To determine the role of SPEG in healthy and failing adult hearts. METHODS AND RESULTS: Proteomic analysis of immunoprecipitated JMC proteins ryanodine receptor type 2 and junctophilin-2 (JPH2) followed by mass spectrometry identified the serine-threonine kinase SPEG as the only novel binding partner for both proteins. Real-time polymerase chain reaction revealed the downregulation of SPEG mRNA levels in failing human hearts. A novel cardiac myocyte-specific Speg conditional knockout (MCM-Spegfl/fl) model revealed that adult-onset SPEG deficiency results in heart failure (HF). Calcium (Ca2+) and transverse-tubule imaging of ventricular myocytes from MCM-Spegfl/fl mice post HF revealed both increased sarcoplasmic reticulum Ca2+ spark frequency and disrupted JMC integrity. Additional studies revealed that transverse-tubule disruption precedes the development of HF development in MCM-Spegfl/fl mice. Although total JPH2 levels were unaltered, JPH2 phosphorylation levels were found to be reduced in MCM-Spegfl/fl mice, suggesting that loss of SPEG phosphorylation of JPH2 led to transverse-tubule disruption, a precursor of HF development in SPEG-deficient mice. CONCLUSIONS: The novel JMC protein SPEG is downregulated in human failing hearts. Acute loss of SPEG in mouse hearts causes JPH2 dephosphorylation and transverse-tubule loss associated with downstream Ca2+ mishandling leading to HF. Our study suggests that SPEG could be a novel target for the treatment of HF.
Authors: Dariush Mozaffarian; Emelia J Benjamin; Alan S Go; Donna K Arnett; Michael J Blaha; Mary Cushman; Sandeep R Das; Sarah de Ferranti; Jean-Pierre Després; Heather J Fullerton; Virginia J Howard; Mark D Huffman; Carmen R Isasi; Monik C Jiménez; Suzanne E Judd; Brett M Kissela; Judith H Lichtman; Lynda D Lisabeth; Simin Liu; Rachel H Mackey; David J Magid; Darren K McGuire; Emile R Mohler; Claudia S Moy; Paul Muntner; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Graham Nichol; Latha Palaniappan; Dilip K Pandey; Mathew J Reeves; Carlos J Rodriguez; Wayne Rosamond; Paul D Sorlie; Joel Stein; Amytis Towfighi; Tanya N Turan; Salim S Virani; Daniel Woo; Robert W Yeh; Melanie B Turner Journal: Circulation Date: 2016-01-26 Impact factor: 29.690
Authors: Pankaj B Agrawal; Christopher R Pierson; Mugdha Joshi; Xiaoli Liu; Gianina Ravenscroft; Behzad Moghadaszadeh; Tiffany Talabere; Marissa Viola; Lindsay C Swanson; Göknur Haliloğlu; Beril Talim; Kyle S Yau; Richard J N Allcock; Nigel G Laing; Mark A Perrella; Alan H Beggs Journal: Am J Hum Genet Date: 2014-07-31 Impact factor: 11.025
Authors: Thomas H Fischer; Jonas Herting; Theodor Tirilomis; André Renner; Stefan Neef; Karl Toischer; David Ellenberger; Anna Förster; Jan D Schmitto; Jan Gummert; Friedrich A Schöndube; Gerd Hasenfuss; Lars S Maier; Samuel Sossalla Journal: Circulation Date: 2013-07-19 Impact factor: 29.690
Authors: Xiaoli Liu; Tripurasundari Ramjiganesh; Yen-Hsu Chen; Su Wol Chung; Sean R Hall; Scott L Schissel; Robert F Padera; Ronglih Liao; Kate G Ackerman; Jan Kajstura; Annarosa Leri; Piero Anversa; Shaw-Fang Yet; Matthew D Layne; Mark A Perrella Journal: Circulation Date: 2008-12-31 Impact factor: 29.690
Authors: Andrew P Landstrom; Noah Weisleder; Karin B Batalden; J Martijn Bos; David J Tester; Steve R Ommen; Xander H T Wehrens; William C Claycomb; Jae-Kyun Ko; Moonsun Hwang; Zui Pan; Jianjie Ma; Michael J Ackerman Journal: J Mol Cell Cardiol Date: 2007-04-18 Impact factor: 5.000
Authors: Min Jiang; Junping Hu; Frances K H White; Judy Williamson; Andrey S Klymchenko; Akshay Murthy; Samuel W Workman; Gea-Ny Tseng Journal: J Biol Chem Date: 2019-07-23 Impact factor: 5.157
Authors: Denis Kusić; Joanne Connolly; Heikki Kainulainen; Ekaterina A Semenova; Oleg V Borisov; Andrey K Larin; Daniil V Popov; Edward V Generozov; Ildus I Ahmetov; Steven L Britton; Lauren G Koch; Jatin G Burniston Journal: Physiol Genomics Date: 2019-12-02 Impact factor: 3.107